Research

Energy balance

There is a need to expand existing clinical recommendations for the treatment of patients with obesity.

Healthcare providers should consider integrating new pharmacotherapies into their treatment plans for obesity.

StrongSupportsmedium confidence
The data obtained regarding the effectiveness of the above drugs indicate the need to expand existing clinical recommendations for the treatment of patients with obesity.
Vadim V. Abramov et al. · Glavvrač (Chief Medical Officer) · 2024

Why this rating

The claim is based on data regarding drug effectiveness.

Source

Possibilities of using glucagon-like peptide-1 agonists and incretin multi-agonists in pharmacotherapy of obesity and metabolic syndrome

Vadim V. Abramov et al. · Glavvrač (Chief Medical Officer) · 2024

DOI 10.33920/med-03-2407-03

review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →